Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials

Dermatology and Therapy ◽

10.1007/s13555-021-00660-3 ◽

2021 ◽

Author(s):

Mark G. Lebwohl ◽

Ahmed M. Soliman ◽

Hongbo Yang ◽

Jessie Wang ◽

Kaitlin Hagan ◽

...

Keyword(s):

Clinical Trials ◽

Severe Psoriasis ◽

Phase 3 ◽

Post Hoc Analysis ◽

Download Full-text

Maintenance of response to brodalumab at 52 weeks among patients with moderate-to-severe psoriasis: Post hoc analysis of two phase 3 studies

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.749 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB185

Keyword(s):

Severe Psoriasis ◽

Phase 3 ◽

Two Phase ◽

Post Hoc Analysis ◽

Download Full-text

HIGHER HAREFIELD CLEANSING SCALE SCORES ARE ASSOCIATED WITH IMPROVED LESION DETECTION: POST HOC ANALYSIS OF THREE RANDOMISED AND CENTRAL READER-ASSESSED PHASE 3 CLINICAL TRIALS

10.1055/s-0038-1637286 ◽

2018 ◽

Author(s):

J Manning ◽

C Hassan ◽

J Halonen ◽

B Amlani ◽

M Epstein

Keyword(s):

Clinical Trials ◽

Lesion Detection ◽

Phase 3 ◽

Post Hoc Analysis ◽

Scale Scores ◽

Download Full-text

COLON CLEANSING EFFICACY AND SAFETY OF 1L NER1006 IN PATIENTS WITH MILD TO MODERATE RENAL IMPAIRMENT: POST HOC ANALYSIS OF RANDOMISED PHASE 3 CLINICAL TRIALS

10.1055/s-0039-1681377 ◽

2019 ◽

Author(s):

C Hassan ◽

H Thompson ◽

S Mokashi ◽

J Drenth

Keyword(s):

Clinical Trials ◽

Renal Impairment ◽

Moderate Renal Impairment ◽

Efficacy And Safety ◽

Phase 3 ◽

Post Hoc Analysis ◽

Colon Cleansing ◽

Download Full-text

HIGH CLEANSING EFFICACY WITH OVERNIGHT SPLIT DOSING 1 L NER1006 IN BOTH MEN AND WOMEN: POST HOC ANALYSIS OF TWO RANDOMISED PHASE 3 CLINICAL TRIALS

10.1055/s-0040-1704897 ◽

2020 ◽

Author(s):

J Manning ◽

L Clayton ◽

MA Alvarez-Gonzalez

Keyword(s):

Clinical Trials ◽

Phase 3 ◽

Men And Women ◽

Post Hoc Analysis ◽

Split Dosing ◽

Download Full-text

25800 Bimekizumab for the treatment of moderate to severe psoriasis of the scalp: Post hoc analysis from the BE SURE phase 3 trial

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.307 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB70

Author(s):

Kristian Reich ◽

Joseph F. Merola ◽

Boni Elewski ◽

Kim A. Papp ◽

Luis Puig ◽

...

Keyword(s):

Severe Psoriasis ◽

Phase 3 ◽

Post Hoc Analysis ◽

Download Full-text

26874 Long-term efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who were partial responders or nonresponders to etanercept: Post hoc analysis through 5 years from the reSURFACE 2 phase 3 trial

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.496 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB119

Author(s):

Diamant Thaçi ◽

Christopher E.M. Griffiths ◽

Lars Iversen ◽

Andrea Peserico ◽

Ignasi Pau-Charles ◽

...

Keyword(s):

Severe Psoriasis ◽

Efficacy And Safety ◽

Phase 3 ◽

Post Hoc Analysis ◽

Term Efficacy ◽

Download Full-text

High Quality Colon Cleansing Improves Polyp and Adenoma Detection Rates: Post hoc Analysis of 1,749 Patients in 3 Randomized Phase 3 Clinical Trials: 2017 Presidential Poster Award

The American Journal of Gastroenterology ◽

10.14309/00000434-201710001-00255 ◽

2017 ◽

Vol 112 ◽

pp. S140-S141

Author(s):

Cesare Hassan ◽

Jonathan Manning ◽

Bharat Amlani ◽

Michael Epstein

Keyword(s):

Clinical Trials ◽

High Quality ◽

Phase 3 ◽

Detection Rates ◽

Post Hoc Analysis ◽

Colon Cleansing ◽

Adenoma Detection ◽

Poster Award ◽

Adenoma Detection Rates ◽

Download Full-text

Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials

Infectious Diseases and Therapy ◽

10.1007/s40121-018-0218-x ◽

2018 ◽

Vol 7 (4) ◽

pp. 473-484 ◽

Author(s):

Tram T. Tran ◽

Darshan Mehta ◽

Federico Mensa ◽

Caroline Park ◽

Yanjun Bao ◽

...

Keyword(s):

Clinical Trials ◽

Renal Function ◽

Hepatitis C ◽

Phase 3 ◽

Hepatitis C Treatment ◽

Post Hoc Analysis ◽

Metabolic Outcomes ◽

Stable Renal Function ◽

Download Full-text

Determinants of Patient’s Global Assessment of Disease Activity and Physician’s Global Assessment of Disease Activity in patients with rheumatoid arthritis: A post hoc analysis of overall and Japanese results from phase 3 clinical trials

Modern Rheumatology ◽

10.1080/14397595.2017.1422304 ◽

2018 ◽

Vol 28 (6) ◽

pp. 960-967 ◽

Author(s):

Yuko Kaneko ◽

Tsutomu Takeuchi ◽

Zhihong Cai ◽

Masayo Sato ◽

Kenta Awakura ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trials ◽

Disease Activity ◽

Global Assessment ◽

Phase 3 ◽

Post Hoc Analysis ◽

Post Hoc ◽

Assessment Of Disease Activity

Download Full-text

Virological outcomes of EVG/COBI/FTC/TDF and EVG/COBI/FTC/TAF in antiretroviral-naive HIV-1-infected participants with baseline HIV-1 RNA >= 1,000,000 copies/ml: a post hoc analysis of Phase 3 clinical trials

Antiviral Therapy ◽

10.3851/imp3187 ◽

2017 ◽

Vol 23 (1) ◽

pp. 95-99

Author(s):

Paul Sax ◽

Edwin DeJesus ◽

David Wohl ◽

Jennifer DeMorin ◽

Damian McColl ◽

...

Keyword(s):

Clinical Trials ◽

Phase 3 ◽

Post Hoc Analysis ◽

Virological Outcomes ◽

Post Hoc ◽

Download Full-text